[Pharmacodynamic and metabolic characteristics of a new dermosteroid: Formocortal].
D000284:Administration, Oral; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000378:metabolism / Q000494:pharmacology*; D000311:Adrenal Glands / Q000187:drug effects*; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010912:Pituitary-Adrenal Function Tests; D011241:Prednisone / Q000494:pharmacology; D012869:Skin Absorption
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D009824:Ointments; D005446:Fluocinolone Acetonide; D011241:Prednisone
Caratteristiche farmacocinetiche e metaboliche di un nuovo dermosteroide: il Formocortal.